Presence of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa

被引:0
|
作者
Okino, T
Egami, H
Ohmachi, H
Takai, E
Tamori, Y
Nakagawa, K
Nakano, S
Akagi, J
Sakamoto, O
Suda, T
Ogawa, M
机构
[1] Kumamoto Univ, Sch Med, Dept Surg 2, Kumamoto 860, Japan
[2] Kumamoto Univ, Sch Med, Dept Mol Pathol, Kumamoto 860, Japan
关键词
RON; splicing variant; colon cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The presence of RON and its variant isoform in malignant and non-malignant human colonic tissues was examined by immunohistochemistry using paraffin-embedded sections and RT-PCR analysis followed by direct sequencing of PCR product using RNAs isolated from frozen tissues. In normal colonic mucosa, RON was uniformly expressed in crypt cells, especially in the bottom of crypta. On the other hand, the expression was distributed heterogeneously in adenomas and in colon cancer. The expression of RON was significantly related to the degree of differentiation of colon cancer and the deletion of the expression was observed in colon cancer specimens with high incidence. The RT-PCR analysis of RNA isolated from non-malignant and malignant colonic tissue revealed the presence of two RON mRNA isoforms with 432-bp and 286-bp. Direct sequecing of major product of 432-bp was revealed to be identical to that of human wild-type RON. On the other hand, major product of 286-bp was revealed to be almost identical to that of a splicing variant of RON transcript which has been found in human gastric cancer cell line, KATO-III. The results obtained in this study may indicate that both wild-type RON and its variant isoform play an important role in regulating the normal function of colonic mucosa such as differentiation and motile activity and the expression of both wild-type RON and its variant isoform could be considered to be reduced during malignancy of human colonic mucosa.
引用
收藏
页码:709 / 714
页数:6
相关论文
共 48 条
  • [1] Analysis of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa
    Okino, T
    Egami, H
    Ohmachi, H
    Takai, E
    Tamori, Y
    Nakagawa, K
    Nakano, S
    Akagi, J
    Sakamoto, O
    Suda, T
    Ogawa, M
    BIOLOGICAL RESPONSE TO PLANNED AND UNPLANNED INJURIES: CELLULAR, MOLECULAR AND GENETIC ASPECTS, 2003, 1255 : 271 - 274
  • [2] Targeting non-malignant disorders with tyrosine kinase inhibitors
    Friedrich Grimminger
    Ralph T. Schermuly
    Hossein A. Ghofrani
    Nature Reviews Drug Discovery, 2010, 9 : 956 - 970
  • [3] Targeting non-malignant disorders with tyrosine kinase inhibitors
    Grimminger, Friedrich
    Schermuly, Ralph T.
    Ghofrani, Hossein A.
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (12) : 956 - 970
  • [4] TRANSFERRIN RECEPTOR IN NON-MALIGNANT AND MALIGNANT HUMAN-BREAST
    WALKER, RA
    DAY, SJ
    JOURNAL OF PATHOLOGY, 1985, 145 (01): : A72 - A72
  • [5] Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers
    Wang, Ming-hai
    Yao, Hang-ping
    Zhou, Yong-qing
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (06) : 641 - 650
  • [6] Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers
    Ming-hai Wang
    Hang-ping Yao
    Yong-qing Zhou
    Acta Pharmacologica Sinica, 2006, 27 : 641 - 650
  • [7] Oncogenesis of RON receptor tyrosine kinase:a molecular target for malignant epithelial cancers
    Ming-hai WANG~(2
    3 Cancer Biology Center and Department of Pharmaceutical Sciences
    ActaPharmacologicaSinica, 2006, (06) : 641 - 650
  • [8] Presence of Human Papillomavirus DNA in Malignant Neoplasia and Non-Malignant Breast Disease
    Maldonado-Rodriguez, Erika
    Hernandez-Barrales, Marisa
    Reyes-Lopez, Adrian
    Godina-Gonzalez, Susana
    Gallegos-Flores, Perla, I
    Esparza-Ibarra, Edgar L.
    Gonzalez-Curiel, Irma E.
    Aguayo-Rojas, Jesus
    Lopez-Saucedo, Adrian
    Mendoza-Almanza, Gretel
    Ayala-Lujan, Jorge L.
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (08) : 3648 - 3665
  • [9] RON receptor tyrosine kinase as a potential translational therapeutic target in malignant pleural mesothelioma
    Easty, D.
    Gray, S. G.
    Nonaka, D.
    Soltermann, A.
    Murer, B.
    Kennedy, M. J.
    Mutti, L.
    Pass, H. I.
    O'Donnell, D. M.
    O'Byrne, K. J.
    LUNG CANCER, 2010, 67 : S19 - S20
  • [10] Agonistic monoclonal antibodies potentiate tumorigenic and invasive activities of splicing variant of the RON receptor tyrosine kinase
    Yao, Hang-Ping
    Luo, Yu-Lan
    Feng, Lei
    Cheng, Lin-Fang
    Lu, Yi
    Li, Wei
    Wang, Ming-Hai
    CANCER BIOLOGY & THERAPY, 2006, 5 (09) : 1179 - 1186